|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/00 | |
| A61P 7/06 | |||
| C07K 14/71 |
| (11) | Patento numeris | 3117829 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16186033.3 |
| Europos patento paraiškos padavimo data | 2010-08-13 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-01-18 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-10-07 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| PCT/US2009/0046 | 2009-08-13 | WO | |
| 583177 | 2009-08-13 | US | |
| 305901 P | 2010-02-18 | US |
| (72) |
SEEHRA, Jasbir, US
PEARSALL, Robert, Scott, US
KUMAR, Ravindra, US
|
| (73) |
Acceleron Pharma Inc.,
128 Sidney Street, Cambridge, MA 02139,
US
|
| (54) | COMBINED USE OF GDF TRAPS AND ERYTHROPOIETIN RECEPTOR ACTIVATORS TO INCREASE RED BLOOD CELL LEVELS |
| COMBINED USE OF GDF TRAPS AND ERYTHROPOIETIN RECEPTOR ACTIVATORS TO INCREASE RED BLOOD CELL LEVELS |